ARL vs IONS · P/E 20, rev $12.9M vs rev $514.0M
American Realty Investors Inc (ARL) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
American Realty Investors Inc (ARL) is a real estate services company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported ARL revenue for 2026-06-30 was $12.9M. Net income was -$1.0M. Revenue was up 4.3% from 2026-03-31 to 2026-06-30. ARL currently screens at market cap $242.3M and trailing P/E 19.7.
Latest reported IONS revenue for 2026-06-30 was $514.0M. Net income was -$207.2M. IONS currently screens at market cap $12.28B.
ARL currently screens at market cap $242.3M and trailing P/E 19.7. IONS currently screens at market cap $12.28B.
Not investment advice. Open the ARL and IONS stock pages for the full models.
Not investment advice.